R1 RCM: TowerBrook and CD&R $8.9B take-private (2024)
In August 2024, TowerBrook Capital Partners and CD&R agreed to acquire R1 RCM in an all-cash transaction valuing the company at approximately $8.9 billion . The take-private closed later in 2024, ending R1’s Nasdaq listing.
R1 RCM provides technology-enabled revenue cycle management and patient experience services for US health systems and physician groups. TowerBrook was already a significant shareholder before partnering with CD&R on the full buyout, combining healthcare services expertise with CD&R’s operating model.
